Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New osteoarthritis treatment candidate blocks cartilage degradation

Nov. 18, 1998

MK-966 improves physical ability and quality of life in patients with OA, RA

Nov. 18, 1998

Amgen evaluates novel TNF-targeted immunotherapy in patients with active RA

Nov. 17, 1998

Stromelysin inhibitor Bay-12-9566 enters clinical testing for a second indication

Nov. 17, 1998

TheraTech achieves targeted delivery of doxorubicin to inflammatory sites in mice with CIA

Nov. 16, 1998

Celecoxib studies continue to generate impressive efficacy and safety data

Nov. 16, 1998

Boston Life Sciences presents amiprilose phase III data at ACR meeting

Nov. 16, 1998

rHuIL-4 safe in patients with RA; efficacy studies are indicated

Nov. 16, 1998

Nonantimicrobial tetracycline exerts antiarthritic effects via upregulation of IL-10 production

Nov. 16, 1998

Hydroxamic acid compounds as inhibitors of TNF production and/or MMPs

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...